This project aims to produce a condom that people actually want to use. If achieved this would revolutionise safe sex, STI prevention and family planning.
With funding from the Victorian Medical Research Acceleration Fund (VMRAF), Burnet Institute and Eudaemon Technologies are currently undertaking a pilot functionality study of the Geldom. The initial phase of this study will assess the safety, acceptability and preference of the Geldom in comparison to a standard commercial condom.
2020-2022
The HIV Prevention group is playing a crucial role in monitoring the outcomes of the PrEPX trial in Victoria. Data collection, including through the ACCESS surveillance system, is monitoring crucial implementation outcomes such as the effectiveness of PrEP and its impact on sexual behaviours and sexually transmitted infections.
We will also monitor the background incidence of HIV among gay men attending PrEP implementation clinics, undertaking world-leading research to measure the impact of rapid PrEP scale-up on background rates of HIV transmission.
Funding
Partners
- Victorian Medical Research Acceleration Fund (VMRAF)
- Bill and Melinda Gates Foundation
Partners +
Collaborators
- Eudaemon Technologies
- Swinburne University
- University of Wollongong
- Essential Access Health
Project
Team
Meet the project team. Together, we are translating research into better health, for all.
